Skip to main content
Caplight Logo









Mevia AB

Mevia AB

Private
GothenburgHealthcare & Life Scienceshttps://mevia.se

Last Round

Early Funding

Mar 11, 2022

Est. Valuation

$1.81M

Total Funding Raised

$1.09M

Company Overview

Mevia AB is a healthcare services company that develops intelligent medication packaging and digital solutions to improve patient medication adherence.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical Devices, Health IoT, Patient Engagement

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS

AI Layer

Non-AI

Keywords

medication adherencesmart packagingclinical trialsconnected healthpatient monitoringdigital healthhealth IoTmedtechpatient engagementclinical research organizationsCROmedication complianceadherence platformremote patient monitoringRPM

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mevia AB Comparables

Compare Mevia AB with similar companies based on industry and business-model similarity.

Mevia AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pill Connect Limited
89%
Information Mediary Corp.
87%
iZafe Group
79%

Mevia AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 11, 2022
SeedOct 1, 2019
AcceleratorJan 16, 2019
SeedDec 17, 2015
SeedSep 1, 2015

Key People

Founding team and executive leadership

Jesper Hassel

CEO & Co-Founder

Founding Team

Mikael Sander

CEO Chairman

Executive Team

Mevia AB Investors

Notable investors and investment history

Mevia AB investors
InvestorRounds
Almi Invest ABSeed
Chalmers VenturesSeed, Early Funding
Merck AcceleratorAccelerator
Spira Invest ABSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2026

    Monthly visitors grew 448% MoM, reaching 2.9K.

  • Jan 16, 2019

    Merck Accelerator led the funding round.

Mevia AB Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mevia AB Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mevia AB's valuation, stock price, and market status.

Firmographic Details

HeadquartersGothenburg
Employee Range4
Year Founded2014
Last FundingMar 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?